135 related articles for article (PubMed ID: 6265369)
21. Specificity of in vitro cytotoxic T cell clones directed against vesicular stomatitis virus.
Rosenthal KL; Oldstone MB; Hengartner H; Zinkernagel RM
J Immunol; 1983 Jul; 131(1):475-8. PubMed ID: 6190924
[TBL] [Abstract][Full Text] [Related]
22. Development of an immunoelectroosmophoresis test for the detection and typing of antibodies to vesicular stomatitis viruses.
Wilks CR; Jenney EW; House JA
Can J Comp Med; 1984 Apr; 48(2):179-83. PubMed ID: 6326981
[TBL] [Abstract][Full Text] [Related]
23. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells.
Zinkernagel RM; Althage A; Holland J
J Immunol; 1978 Aug; 121(2):744-8. PubMed ID: 210232
[TBL] [Abstract][Full Text] [Related]
24. Effect of strain and serotype of vesicular stomatitis virus on viral shedding, vesicular lesion development, and contact transmission in pigs.
Stallknecht DE; Greer JB; Murphy MD; Mead DG; Howerth EW
Am J Vet Res; 2004 Sep; 65(9):1233-9. PubMed ID: 15478770
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility and serological response of cattle, pigs, horses and goats to Indiana2 and Indiana3 strains of vesicular stomatitis virus.
Yedloutschnig RJ; Dardiri AH
Proc Annu Meet U S Anim Health Assoc; 1977; (81):276-83. PubMed ID: 220637
[No Abstract] [Full Text] [Related]
26. Cytotoxic T lymphocytes reactive with vesicular stomatitis virus: analysis of specificity with monoclonal antibodies directed to the viral glycoprotein.
Lefrancois L; Lyles DS
J Immunol; 1983 Mar; 130(3):1408-12. PubMed ID: 6185583
[TBL] [Abstract][Full Text] [Related]
27. Elicitation of natural killer cells in beige mice by infection with vesicular stomatitis virus.
McKinnon KP; Hale AH; Ruebush MJ
Infect Immun; 1981 Apr; 32(1):204-10. PubMed ID: 6163720
[TBL] [Abstract][Full Text] [Related]
28. Inability of mice to generate cytotoxic T lymphocytes to vesicular stomatitis virus restricted to H-2Kk or H-2Dk.
Rosenthal KL; Zinkernagel RM
J Immunol; 1981 Feb; 126(2):446-51. PubMed ID: 6256440
[TBL] [Abstract][Full Text] [Related]
29. SV40 tumor rejection induced by vesicular stomatitis virus bearing SV40 tumor-specific transplantation antigen (SV40-TSTA). II. Association of SV40-TSTA activity with liposomes containing VSV glycolipids.
Huet C; Ansel S
Int J Cancer; 1977 Jul; 20(1):61-6. PubMed ID: 71275
[TBL] [Abstract][Full Text] [Related]
30. On the mechanism of neurotropism of vesicular stomatitis virus in newborn hamsters. Studies with temperature-sensitive mutants.
Stanners CP; Goldberg VJ
J Gen Virol; 1975 Dec; 29(3):281-96. PubMed ID: 173795
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the Impact of Oncolytic Vesicular Stomatitis Virus on the Trafficking, Phenotype, and Antigen Presentation Potential of Neutrophils and Their Ability to Acquire a Non-Structural Viral Protein.
Stegelmeier AA; Chan L; Mehrani Y; Petrik JJ; Wootton SK; Bridle B; Karimi K
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882969
[TBL] [Abstract][Full Text] [Related]
32. Genetic analyses of alloreactions between recently wild and classical inbred strains of Syrian hamsters: evidence in favor of a major histocompatibility complex.
Duncan WR; Streilein JW
Immunogenetics; 1981; 13(5):393-403. PubMed ID: 6457794
[TBL] [Abstract][Full Text] [Related]
33. Augmentation of delayed-type hypersensitivity to serum proteins by vesicular stomatitis virus infection in mice: virus-suppressor cell interactions.
Katsura Y; Takaoki Y; Minato N
J Immunol; 1982 Jul; 129(1):362-5. PubMed ID: 6177756
[TBL] [Abstract][Full Text] [Related]
34. Reconstitution with T lymphocytes protects nude mice from a central nervous system disorder induced by a temperature-sensitive vesicular stomatitis virus.
Doll SC; Johnson TC
J Gen Virol; 1988 Aug; 69 ( Pt 8)():1969-77. PubMed ID: 2841409
[TBL] [Abstract][Full Text] [Related]
35. Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis.
Mills BJ; Beebe DP; Cooper NR
J Immunol; 1979 Dec; 123(6):2518-24. PubMed ID: 227957
[TBL] [Abstract][Full Text] [Related]
36. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo.
Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM
J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445
[TBL] [Abstract][Full Text] [Related]
37. Minimal molecular and cellular requirements for elicitation of secondary anti-vesicular stomatitis virus cytotoxic T lymphocytes.
Hale AH; Ruebush MJ
J Immunol; 1980 Oct; 125(4):1569-77. PubMed ID: 6251135
[No Abstract] [Full Text] [Related]
38. Association of reduced interleukin-2 production with genetic susceptibility to Pichinde virus in inbred strains of hamsters.
Wright KE; Rosenthal KL; Rawls WE
Arch Virol; 1987; 92(3-4):197-209. PubMed ID: 3028332
[TBL] [Abstract][Full Text] [Related]
39. Cooperation of B cells and T cells is required for survival of mice infected with vesicular stomatitis virus.
Thomsen AR; Nansen A; Andersen C; Johansen J; Marker O; Christensen JP
Int Immunol; 1997 Nov; 9(11):1757-66. PubMed ID: 9418136
[TBL] [Abstract][Full Text] [Related]
40. The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus.
Gobet R; Cerny A; Rüedi E; Hengartner H; Zinkernagel RM
Exp Cell Biol; 1988; 56(4):175-80. PubMed ID: 2849570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
